Development of a drug screening pipeline for discovery of novel COVID-19 therapeutics#
Currently, there are no effective drugs available to fight SARS coronavirus-2 (SARS-CoV-2) and the associated disease, COVID-19. The working group on High-Throughput Drug and Target Discovery at Fraunhofer ITEM in Regensburg is cooperating with partners from the University of Regensburg and the company 2bind GmbH, aiming to identify drug candidates that specifically inhibit packaging of the SARS-CoV-2 genome into virus particles and thereby prevent replication of the virus. The project will be funded by the Bavarian Research Foundation for a period of one year, starting in December 2020.
Read the news of December 16, 2020: Development of a drug screening pipeline for discovery of novel COVID-19 therapeutics
Our Contact: Dr. Kamran Honarnejad